New generic competitors emerge for Topamax

With Mylan's period of exclusivity over, a slew of generics makers got final FDA approval to sell their versions of Johnson & Johnson's anti-seizure drug Topamax: Ranbaxy Laboratories, Aurobindo Pharma, Teva Pharmaceutical Industries, Unichem Laboratories, Aurobindo Pharma, Zydus Pharmaceuticals and Sun Pharma. Look for prices to fall accordingly. Report | Report | Report l Report